Kunzendorf U - Search Results

1

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant.

Hock H, Dorsch M, Kunzendorf U, Uberla K, Qin Z, Diamantstein T, Blankenstein T. Hock H, et al. Among authors: kunzendorf u. Cancer Res. 1993 Feb 15;53(4):714-6. Cancer Res. 1993. PMID: 7679048

2

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.

Qin Z, Krüger-Krasagakes S, Kunzendorf U, Hock H, Diamantstein T, Blankenstein T. Qin Z, et al. Among authors: kunzendorf u. J Exp Med. 1993 Jul 1;178(1):355-60. doi: 10.1084/jem.178.1.355. J Exp Med. 1993. PMID: 8315391 Free PMC article.

3

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.

Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T. Hock H, et al. Among authors: kunzendorf u. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2774-8. doi: 10.1073/pnas.90.7.2774. Proc Natl Acad Sci U S A. 1993. PMID: 8464888 Free PMC article.

4

A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin.

Kunzendorf U, Krüger-Krasagakes S, Notter M, Hock H, Walz G, Diamantstein T. Kunzendorf U, et al. Cancer Res. 1994 Feb 15;54(4):1109-12. Cancer Res. 1994. PMID: 7508820

5

Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy.

Hock H, Dorsch M, Richter G, Kunzendorf U, Krüger-Krasagakes S, Blankenstein T, Qin Z, Diamantstein T. Hock H, et al. Among authors: kunzendorf u. Nat Immun. 1994 Mar-Jun;13(2-3):85-92. Nat Immun. 1994. PMID: 8173239 Review.

6

Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression.

Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blankenstein T. Dorsch M, et al. Among authors: kunzendorf u. Eur J Immunol. 1993 Jan;23(1):186-90. doi: 10.1002/eji.1830230129. Eur J Immunol. 1993. PMID: 8419170

7

Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.

Bulfone-Paus S, von Bernuth H, Rückert R, Wachtlin J, Ungureanu D, Notter M, Krause H, Pohl T, Paus R, Kunzendorf U. Bulfone-Paus S, et al. Among authors: kunzendorf u. Cancer Res. 1998 Jul 1;58(13):2707-10. Cancer Res. 1998. PMID: 9661877

8

T cells bind to the endothelial adhesion molecule GMP-140 (P-selectin).

Kunzendorf U, Notter M, Hock H, Distler A, Diamantstein T, Walz G. Kunzendorf U, et al. Transplantation. 1993 Nov;56(5):1213-7. doi: 10.1097/00007890-199311000-00031. Transplantation. 1993. PMID: 7504345

9

Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.

Kunzendorf U, Pohl T, Bulfone-Paus S, Krause H, Notter M, Onu A, Walz G, Diamantstein T. Kunzendorf U, et al. J Clin Invest. 1996 Mar 1;97(5):1204-10. doi: 10.1172/JCI118534. J Clin Invest. 1996. PMID: 8636431 Free PMC article.

10

Factors influencing the response to hepatitis B vaccination of hemodialysis patients.

Walz G, Kunzendorf U, Haller H, Keller F, Offermann G, Josimovic-Alasevic O, Diamantstein T. Walz G, et al. Among authors: kunzendorf u. Nephron. 1989;51(4):474-7. doi: 10.1159/000185379. Nephron. 1989. PMID: 2525677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters